RFCL acquires Bremer Pharma

RFCL, an ICICI Venture company, has made first its global acquisition in the space of veterinary healthcare through a share purchase agreement with Marsing & Co A/S for its Germany-based subsidiary Bremer Pharma GmbH.

NEW DELHI: RFCL, an ICICI Venture company, has made first its global acquisition in the space of veterinary healthcare through a share purchase agreement with Marsing & Co A/S for its Germany-based subsidiary Bremer Pharma GmbH. The deal will put RFCL among the world���s 25 global integrated veterinary healthcare business, a company release said.

The company did not disclose the financial details of the agreement. The agreement is for transfer of all key people, assets, brands and the name ���Bremer Pharma��� and all contracts including exports.

RFCL will gain a marketing foothold and a manufacturing base in the country. The facility has a processing capacity of nearly 6.6 lakh litres of liquids per annum per shift, nearly 1,032 tonnes of solids per annum per shift and 15 lakh vials of sterile solutions per annum per shift.

Bremer Pharma is into research, manufacturing and supply of veterinary medical through a network across Europe, Middle East, Asia and Africa.
READ MORE
ADVERTISEMENT

LOGIN & CLAIM

50 TIMESPOINTS

More from our Partners

Loading next story
Business News › Industry › Healthcare/Biotech › Pharmaceuticals › RFCL acquires Bremer Pharma
Text Size:AAA
Success
This article has been saved

*

+